GenStar

enStar Therapeutics is a biopharmaceutical company developing innovative gene therapy products, for the treatment of serious medical disorders. The Company’s research and development efforts, utilizing advanced gene delivery technologies,

are focused on hemophilia, cancer, and HIV/AIDS. Strategically, GenStar is leveraging its technology

assets through product and technology collaborations.

Contact Details: 10865 Altman Row San Diego CA 92121 United States of America Tel: (858) 450 5949 Fax: (858) 450 0425 Email: ir@genstar-rx.com WWW: www.genstar-rx.com/

Loading...

Recent Publications by GenStar:
A highly efficient gene delivery system derived from feline immunodeficiency virus (FIV). Basic neuroscience research findings during the past five years have...	5th April, 2003	GenStar Therapeutics Inc., San Diego, CA, USA.	Methods Mol Med. 2003;76:405-32.
FIV vector systems. Why is feline immunodeficiency virus (FIV) such an appealing candidate for...	1st January, 2003	GenStar Therapeutics, San Diego, California 92121, USA.	Somat Cell Mol Genet. 2001 Nov;26(1-6):99-129.
Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. The successful prophylactic treatment of hemophilia A by frequent...	26th February, 2000	GenStar Therapeutics Corp, San Diego, CA 92121, USA.	Blood. 2000 Feb 1;95(3):820-8.

Press Releases on GenStar:
Entest BioMedical Inc. Adds Former National Cancer Institute Researcher to Scientific Advisory Board With Focus on Stem Cell Cancer Patient Therapies	8th June, 2009	Bio-Matrix Scientific Group, Inc.	SAN DIEGO, June 8 /PRNewswire-FirstCall/ -- Dr. Steven Josephs, Ph.D., a former National Cancer Institute (NCI) researcher, has joined Entest BioMedical Inc.'s (www.entestbio.com) Science
Commercializing on Tumor Antigens - The Next Wave? - New	1st January, 1970	Bioseeker	Commercializing on Tumor Antigens - The Next Wave? - New "de-novo" analysis from BioSeeker Group - March 2, 2002. Today in Europe

GenStar Patents:
US Patent No.	Title
6403370	Oncolytic/immunogenic complementary-adenoviral vector system
4871605	Inorganic fiber mat based bituminous sheet materials
4680901	Precast concrete dome system
4448690	Subsurface waste disposal system

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 306 times since April 2007, the link to the organisation's website has been followed 72 times

Recent Search Terms used to find this page: genstar patent | mat genster | genstar | GENSTAR download drug | genstar financial | genstar gene therapy | genstar technology usa | gen star | .

Search for more companies in San Diego

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for GenStar